Natural Alternatives International, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, covering the first fiscal quarter of its 2027 fiscal year.

Key Highlights

  • Shares outstanding: As of November 13, 2026, 6,259,181 shares of common stock were outstanding, net of 3,392,725 treasury shares.
  • Total assets: Total assets were $114,531 thousand at September 30, 2026, down from $126,446 thousand at June 30, 2026.
  • Cash position: Cash and cash equivalents stood at $6,485 thousand at September 30, 2026, compared to $7,388 thousand at June 30, 2026.
  • Accounts receivable: Accounts receivable, net of allowances, were $12,426 thousand at September 30, 2026, down from $20,650 thousand at June 30, 2026.
  • Inventories: Net inventories were $28,165 thousand at September 30, 2026, compared to $30,753 thousand at June 30, 2026.
  • Going concern disclosure: The filing states the company described its "ability to continue as a going concern" and generate sufficient liquidity as a forward-looking consideration in its financial statement footnotes.
  • Covenant compliance: The filing identifies "current non-compliance" with credit agreement covenants as a forward-looking risk factor, noting the company's ability to obtain amendments, waivers, or modifications from lenders is not certain.

Balance Sheet Position and Key Disclosures for Natural Alternatives International

Natural Alternatives International, Inc. (NASDAQ:NAII), a Delaware-incorporated nutritional supplement manufacturer headquartered in Carlsbad, California, filed its quarterly report covering the period ended September 30, 2026. According to the filing, the company is classified as a non-accelerated filer and a smaller reporting company. Total assets declined to $114,531 thousand at September 30, 2026, from $126,446 thousand at June 30, 2026, the company's most recent fiscal year-end.

The condensed consolidated balance sheet reported current assets of $54,302 thousand at September 30, 2026, down from $65,434 thousand at June 30, 2026. Within current assets, accounts receivable fell to $12,426 thousand from $20,650 thousand, and inventories decreased to $28,165 thousand from $30,753 thousand. Assets held for sale remained unchanged at $3,977 thousand across both periods. On the liabilities side, accounts payable were $12,873 thousand at September 30, 2026, compared to $18,146 thousand at June 30, 2026, and accrued liabilities declined to $2,760 thousand from $4,601 thousand.

The filing includes a forward-looking statements section identifying several risk areas, including the company's "ability to maintain compliance with the covenants contained in our credit agreements with our lenders in the future and due to the current non-compliance, our ability to obtain amendments, waivers, or modifications from our lenders on acceptable terms, or at all." The company also cited going concern considerations and uncertainty around raw material sourcing, particularly beta-alanine, and potential impacts from new tariffs. These statements are the company's own and are subject to its cautionary language as described in the filing.

What Was Disclosed

Natural Alternatives International filed its quarterly report for the period ended September 30, 2026, disclosing balance sheet data showing declines in total assets, cash, accounts receivable, and inventories relative to June 30, 2026, alongside disclosures regarding covenant non-compliance and going concern considerations.